Maine Academy of Family Physicians

OCTOBER 22, 2023

207-938-5005 info@maineafp.org About About Board of Directors Member Spotlight Physician of the Year Presidents Statement Advocacy Advocacy Advocacy Opportunities in Maine Legislative Advocacy Advocacy Resources Health Equity Career Center Education/News Upcoming Events 33rd Annual MAFP FM Update - 2025 Newsletter - Current Newsletters - Past Resident & Student Interest Residency Programs Membership Practice Resources Billing & Coding Board Certification Direct Primary Care Licensing Req

Family Medicine 52

Family Medicine DO Families Family 52

University of Utah Family Medicine Residency

OCTOBER 25, 2023

by Brian Bertsche, MD Future Medical Professionals, As you continue on your journey through medical school, the choice of your medical specialty is a pivotal decision. The allure of more high-profile specialties may seem appealing at first, but the ever-evolving field of family medicine should not be overlooked.

Family Medicine 52

Family Medicine DO Families Family 52

The Clinical Problem Solvers

OCTOBER 24, 2023

[link] In this Infectious Disease Rafael Medina Subspecialty Episode, Dr. Navila Sharif presents a case to Dr. Natasha Spottiswoode of a patient presenting for fevers and chills. Session facilitator: Youssef Saklawi The goal of this series is to provide greater access to subspecialty, primary care, and internal medicine-adjacent specialty education for learners worldwide.

Internal Medicine 52

Internal Medicine Primary Care Education Diagnose 52

PEMBlog

OCTOBER 26, 2023

Background Meckel diverticulum is a congenital abnormality of the small intestine and is the most common cause of significant lower gastrointestinal bleeding in children. It arises from incomplete involution of the vitelline duct during embryonic development, typically occurring by the 7th week of gestation. It is characterized by a blind-ending true diverticulum that contains all the layers found in the ileum.

Diagnosis 64

Diagnosis Complication Consulting Management 64

FDA Law Blog

OCTOBER 24, 2023

By Dara Katcher Levy — Yesterday, FDA published a new Draft Guidance, “ Communications from Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Questions and Answers ” (SIUU Guidance or Draft Guidance). Previous iterations of this guidance from 2009 and 2014 (blogged on here and here ) were known as Good Reprint Practices (GRP).

Clinic 64

Clinic Clinical Practice Provider Utilities 64

Clinical Correlations

OCTOBER 25, 2023

By Matthew Auda Peer Reviewed Let’s begin with a case. The patient is a 67-year-old female with a past medical history of hypothyroidism referred to your Cardiology Clinic by her primary care physician for cardiovascular disease.

Primary Care Physician 52

Primary Care Physician Clinic Primary Care Medical 52

GeriPal

OCTOBER 26, 2023

Summary Transcript Summary Often podcasts meet clinical reality. That’s why we do this podcast- to address real world issues in palliative care, geriatrics, and bioethics. But rarely does the podcast and clinical reality meet in the same day. Within hours of recording this podcast, I joined a family meeting of an older patient who had multiple medical problems including cancer, and a slow but inexorable decline in function, weight, and cognition.

Patient-Centered 132

Patient-Centered Hospital Patients IT 132

FDA Law Blog

OCTOBER 26, 2023

By Véronique Li, Senior Medical Device Regulation Expert & Anne K. Walsh — In our June blog post , we reported on FDA’s request for comments about its program to receive information from the public alleging misconduct by other companies. FDA uses this program to help it identify risks and to determine whether further investigation is needed. Because this program requires information collection from the public, the Paperwork Reduction Act (PRA) of 1995 (44 U.S.C. 3501) and its implementing

Medical 52

Medical IT Management Provider 52

FDA Law Blog

OCTOBER 24, 2023

By Philip Won & Allyson B. Mullen — As of October 1, 2023, all 510(k) submissions, unless exempted, must be submitted to FDA using the electronic Submission Template And Resource ( eSTAR ). The same template can also be used for De Novo submissions. Currently, eSTAR is voluntary for medical device De Novo submissions, but FDA has initiated the process of requiring De Novos to be submitted using eSTAR.

Medical 52

Medical Electronics Provider Screening 52